TerminatedPhase 4NCT01939691

Macular Edema Nepafenac vs. Difluprednate Uveitis Trial

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Nisha Acharya, MD MS
University of California, San Francisco
Intervention
Difluprednate(drug)
Enrollment
9 target
Eligibility
18 years · All sexes
Timeline
20182020

Study locations (3)

Collaborators

Aravind Eye Hospitals, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01939691 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials